Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
2019 · The Lancet · 2,820 citations
https://doi.org/10.1016/s0140-6736(19)31149-3
N
Núria Alonso
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
140
Papers
5.6K
Citations
28
h-index
66
i10-index
Núria Alonso is an academic researcher from Universitat Autònoma de Barcelona. The author has contributed to research in topics: Cardiovascular Function and Risk Factors & Diabetes, Cardiovascular Risks, and Lipoproteins & Diabetes Treatment and Management. The author has an h-index of 28, co-authored 119 publications.
ORCID: 0000-0001-9687-8050Papers by this author
worksDulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
2019 · The Lancet · 600 citations
https://doi.org/10.1016/s0140-6736(19)31150-x
Type 2 diabetes-associated carotid plaque burden is increased in patients with retinopathy compared to those without retinopathy
2015 · Cardiovascular Diabetology · 59 citations
https://doi.org/10.1186/s12933-015-0196-1
Evaluation of efficacy, safety, pain perception and health-related quality of life of percutaneous ethanol injection as first-line treatment in symptomatic thyroid cysts
2015 · BMC Endocrine Disorders · 43 citations
https://doi.org/10.1186/s12902-015-0069-3
Advanced lipoprotein profile disturbances in type 1 diabetes mellitus: a focus on LDL particles
2020 · Cardiovascular Diabetology · 34 citations
https://doi.org/10.1186/s12933-020-01099-0
Diabetes mellitus y riesgo cardiovascular: recomendaciones del Grupo de Trabajo Diabetes y Enfermedad Cardiovascular de la Sociedad Española de Diabetes (SED, 2015)
2015 · Atención Primaria · 32 citations
https://doi.org/10.1016/j.aprim.2015.05.002
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat